The control of infectious or communicable diseases generally demands in whole or in part management of the environment (water chlorination), law (immunization of school children), behaviour modification (safe sex), drugs (antibiotics, vaccines), and education or propaganda (television, posters). The eventual control of malaria in the South Pacific (SOPAC) and Southwest Pacific Area (SWPA) theatres in World War II required the application in combat of all these variables. It is an exemplary tale of the importance of medical research before and during a war and-more importantly-of the absolute necessity of combat commanders understanding medical advice and applying it through the command chain with military discipline. The reduction of malaria cases is a multi-factorial process. Military personnel must take the prophylactic drugs, use insect repellent, observe clothing discipline, and use bed nets where possible. Dedicated engineering, entomological and preventive medicine units must determine the significant mosquito vectors and destroy their breeding places, define any reservoirs in native inhabitants, and educate troops and their commanders. Civil affairs and medical units must assist in the treatment of any native reservoirs and advise command on the use of native labour as a transmission risk. Malaria was endemic to hyper-endemic in SOPAC and SWPA. It took three campaigns-Bataan, New Guinea and Guadalcanal-to demonstrate what a force destroyer this single disease was. As soon as combat commanders understood what a force multiplier malaria control could be, the resources and command support were given without stint. This paper discusses the operational and medical aspects of malaria in American forces. The lessons apply equally to the Australian army; their story is splendidly told elsewhere.1 Of necessity, the tactical and operational background must be sketched in. Those soldiers and marines were not in the jungles by choice; it was a war that put them there, it was a war that exposed them to malaria, and it was a war that forced the application of peacetime knowledge, and wartime research that eventually solved the military medical problem.
Nine healthy males were infused with norepinephrine (o. μg/kg min) for 20 min before and after five 40-hr weeks of seminude exposure to 5 C. All infusions were given in the basal state, in a quiet room at 27 C, after a 30-min period of control measurements. Rectal temperatures and respiratory rates were unchanged either by the drug or the intervening cold exposure. The drug increased respiratory minute volumes and tidal volumes and decreased heart rates, but equally so in both experiments. Mean skin temperatures were unaffected by the drug but were significantly (P < .025) higher after cold exposure (mean 1 C). Both basal and drug-induced increase above basal of systolic and diastolic blood pressures was significantly lower (P < .025) after cold exposure. Oxygen consumption was the same in both basal periods and was unaffected by the drug before cold exposure. After cold exposure, norepinephrine produced a significant (P < .025) increase in oxygen consumption (mean 18 cc/min m2). These results show a changed sensitivity to norepinephrine in cold-exposed men, with a decrease in vasopressor response and the development of a calorigenic response. The data suggest that in men, norepinephrine may be a mediator of a nonshivering thermogenesis occurring with cold acclimatization. Note: (With the Assistance of Joseph C. Matone, Gerald W. Newcomb, and Wendell C. Bradford) cold exposure; catecholamines; norepinephrine calorigenesis; nonshivering thermogenesis Submitted on May 2, 1963
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.